BIOPOOL INTERNATIONAL INC
10-Q/A, 1996-01-04
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: FASTCOMM COMMUNICATIONS CORP, S-3, 1996-01-04
Next: VISION GROUP OF FUNDS INC, N-30D, 1996-01-04




<PAGE>
_______________________________________________________________________
_________________________________________________________________________

                     SECURITIES AND EXCHANGE COMMISSION
                            WASHINGTON, D.C. 20549

                                  FORM 10-Q
                                       
          /x/   QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF
                       SECURITIES EXCHANGE ACT OF 1934

          / /   TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF
                     THE SECURITIES EXCHANGE ACT OF 1934

                   For the quarter ended September 30, 1995
         ___________________________________________________________

                        COMMISSION FILE NUMBER 0-17714
         ___________________________________________________________

                         BIOPOOL INTERNATIONAL, INC.
            (Exact name of Registrant as specified in its charter)

          DELAWARE                                 58-1729436
(State or other jurisdiction of                 (I.R.S. Employer
 incorporation or organization)                Identification No.)


     6025 Nicolle Street
     Ventura, California                              93003
(Address of principal executive offices)           (Zip Code)
              

Registrant's telephone number, including area code:  805-654-0643

   _______________________________________________________________________

Indicate by check mark whether the Registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the proceeding 12 months (or for such shorter period
that the Registrant was required to file such reports), and (2) has been
subject to such filing requirements for the past 90 days.

                             YES  [X]    NO [ ]

Indicate the number of shares outstanding of each of the issuer's classes
of Common Stock, as of the latest practicable date.

Outstanding at September 30, 1995, Common Stock, $.01 par value per
share, 7,929,096 shares.
  _______________________________________________________________________
  _______________________________________________________________________
                                      



<PAGE>
                           BIOPOOL INTERNATIONAL, INC.
                           CONSOLIDATED BALANCE SHEETS
<TABLE>
<CAPTION>
                                      September 30,     December 31, 
                                          1995              1994
                                       (Unaudited)                    
_______________________________________________________________________
<S>                                   <C>             <C>
ASSETS

CURRENT ASSETS
  Cash and cash equivalents           $  1,678,724    $   1,841,475 
  Accounts receivable, net of
    allowance for doubtful
    accounts (1995 - $5,885,                                        
    1994 - $10,445)                      1,127,446          875,978 
  Inventories                            1,958,597        1,528,696 
  Prepaid expenses and other                                        
    current assets                         369,154          109,939 
_______________________________________________________________________

TOTAL CURRENT ASSETS                     5,133,921        4,356,088 
_______________________________________________________________________

PROPERTY AND EQUIPMENT                   3,320,173        2,480,480 
  Less accumulated depreciation
    and amortization                    (1,575,422)      (1,309,787)
_______________________________________________________________________

PROPERTY AND EQUIPMENT, NET              1,744,751        1,170,693 
_______________________________________________________________________

OTHER ASSETS
  Patent application costs, net            148,827          141,180 
  Excess of cost over net assets
    of acquired companies, net             684,351          725,646 
  Other assets                             309,079           65,055 
_______________________________________________________________________

TOTAL OTHER ASSETS                       1,142,257          931,881 
_______________________________________________________________________

TOTAL ASSETS                          $  8,020,929    $   6,458,662 
_______________________________________________________________________
</TABLE>

See accompanying notes to consolidated financial statements.


                                     3


<PAGE>
                                 SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.





Date:    November 7, 1995             BIOPOOL INTERNATIONAL, INC.
        ___________________           ___________________________

                                      (Registrant)





                                      Michael D. Bick, Ph.D.
                                      ___________________________

                                      Michael D. Bick, Ph.D.
                                      Chief Executive Officer and
                                      Chairman of the Board





                                      Jeffrey C. Hass
                                      ___________________________

                                      Jeffrey C. Hass
                                      Secretary and Director of Finance

                                        11                                  

<TABLE> <S> <C>

<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1995
<PERIOD-END>                               SEP-30-1995
<CASH>                                       1,678,724
<SECURITIES>                                         0
<RECEIVABLES>                                1,133,331
<ALLOWANCES>                                     5,885
<INVENTORY>                                  1,958,597
<CURRENT-ASSETS>                             5,133,921
<PP&E>                                       3,320,173
<DEPRECIATION>                               1,575,422
<TOTAL-ASSETS>                               8,020,929
<CURRENT-LIABILITIES>                        1,349,011
<BONDS>                                              0
                           93,861
                                          0
<COMMON>                                             0
<OTHER-SE>                                   9,488,606
<TOTAL-LIABILITY-AND-EQUITY>                 8,020,929
<SALES>                                      4,977,749
<TOTAL-REVENUES>                             4,977,749
<CGS>                                        2,434,455
<TOTAL-COSTS>                                4,475,431
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              37,444
<INCOME-PRETAX>                                566,215
<INCOME-TAX>                                   131,313
<INCOME-CONTINUING>                            434,902
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   434,902
<EPS-PRIMARY>                                      .06
<EPS-DILUTED>                                      .06
        

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission